Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Erythrosin B (AC159)
Cat.#: ASSD-159
Specifications
Description Erythrosin B, a synthetic dye and stain, is a photosensitizing vital exclusion dye that induces net release of transmitters via vesicles and selectively inhibits neuronal uptake of catecholamines. Synonyms Solvent Red 140; tetra-iodo fluorescein; Ery B; Erythrosin; Erythrosine Size 1g, 5g Chemical Name Solvent Red 140; Tetraiodofluoresceuin; Erythrosine Molecule Weight 835.89 Molecular formula C20H8I4O5 CAS Number 16423-68-0 Storage RT Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-157 Eosin B (AC157) 1g, 5g inquiry ASSD-127 Fluorescent H3 antagonist [clobenpropit] (AC127) 50 μg inquiry ASSD-161 Methylene Blue (AC161) 50 mg, 1 g inquiry ASSD-211 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) 100 mg, 1 g inquiry ASSD-191 Fluorescein 6-Isothiocyanate, Isomer 2, 95% (AC191) 100 mg inquiry ASSD-112 Propidium Iodide Staining Solution (1mg/ml) in water (AC112) 1 mL inquiry ASSD-123 Fluorescent β2 antagonist [(S)-propranolol-red] (AC123) 500 μg inquiry ASSD-107 Modified Mayer's Hematoxylin (AC107) 125 mL, 250 mL, 2×250mL inquiry ASSD-210 7-Amino-4-methyl-3-coumarinacetic acid N-succinimidyl ester (AC210) 5 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket